Ritonavir
Overview
Ritonavir is an antiretroviral agent belongs to the group of known as protease inhibitors, but ritonavir has improved oral bioavailability compared with other protease inhibitors. Ritonavir is used either alone, or in combination with nucleoside reverse transcriptase inhibitor, for the treatment of progressive or advanced HIV infection.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
No data regarding the contra indications of Ritonavir is available.
Back to top
Back to top
Side Effects
Back to top
Dosage
Ritonavir's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 600 mg | 600 (600) | 12 hourly | PO | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Ritonavir is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Ritonavir is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Ritonavir
Back to top
Previous Drug Generic - Next Drug Generic